https://gedatolisibinhibitor.c....om/improved-distinct
Breast cancer stem cells (BCSCs) are believed to be responsible for therapy resistance and cancer recurrence. We recently demonstrated that human BCSCs (CD24-/CD44+) could endure much better than their equivalent non-BCSCs (CD24-/CD44-) when treated with rotenone, possibly because of reduced amounts of reactive oxygen species (ROS) production, large expression of antioxidant manganese superoxide dismutase (MnSOD), and anti-apoptotic survivin. The goal of this research would be to va
Like
Comment
Share
